Abstract
A syndrome similar to idiopathic parkinsonism developed after intravenous self-administration of an illicit drug preparation in which N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (NMPTP) might have been responsible for the toxicity. In the present study we show that intravenous administration of NMPTP to the rhesus monkey produces a disorder like parkinsonism (akinesia, rigidity, postural tremor, flexed posture, eyelid closure, drooling) that is reversed by the administration of L-dopa. NMPTP treatment decreases the release of dopamine and dopamine accumulates in swollen, distorted axons in the nigrostriatal pathway just above the substantia nigra, followed by severe nerve cell loss in the pars compacta of the substantia nigra and a marked reduction in the dopamine content of the striatum. The pathological and biochemical changes produced by NMPTP are similar to the well-established changes in patients with parkinsonism. Thus, the NMPTP-treated monkey provides a model that can be used to examine mechanisms and explore therapies of parkinsonism.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Colburn T. R., Smith B. M., Guarini J. J., Simmons N. N. An ambulatory activity monitor with solid state memory. ISA Trans. 1976;15(2):149–154. [PubMed] [Google Scholar]
- Cotzias G. C., Van Woert M. H., Schiffer L. M. Aromatic amino acids and modification of parkinsonism. N Engl J Med. 1967 Feb 16;276(7):374–379. doi: 10.1056/NEJM196702162760703. [DOI] [PubMed] [Google Scholar]
- Davis G. C., Williams A. C., Markey S. P., Ebert M. H., Caine E. D., Reichert C. M., Kopin I. J. Chronic Parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry Res. 1979 Dec;1(3):249–254. doi: 10.1016/0165-1781(79)90006-4. [DOI] [PubMed] [Google Scholar]
- Finch C. E. Catecholamine metabolism in the brains of ageing male mice. Brain Res. 1973 Mar 30;52:261–276. doi: 10.1016/0006-8993(73)90663-x. [DOI] [PubMed] [Google Scholar]
- Gordon E. K., Oliver J., Black K., Kopin I. J. Simultaneous assay by mass fragmentography of vanillyl mandelic acid, homovanillic acid, and 3-methoxy-4-hydroxy-phenethylene glycol in cerebrospinal fluid and urine. Biochem Med. 1974 Sep;11(1):32–40. doi: 10.1016/0006-2944(74)90092-1. [DOI] [PubMed] [Google Scholar]
- Jenden D. J., Roch M., Booth R. A. Simultaneous measurement of endogenous and deuterium-labeled tracer variants of choline and acetylcholine in subpicomole quantities by gas chromatography-mass spectrometry. Anal Biochem. 1973 Oct;55(2):438–448. doi: 10.1016/0003-2697(73)90134-6. [DOI] [PubMed] [Google Scholar]
- Jimerson D. C., Markey S. P., Oliver J. A., Kopin I. J. Simultaneous measurement of plasma 4-hydroxy-3-methoxyphenylethylene glycol and 3,4-dihydroxyphenylethylene glycol by gas chromatography mass spectrometry. Biomed Mass Spectrom. 1981 Jun;8(6):256–259. doi: 10.1002/bms.1200080606. [DOI] [PubMed] [Google Scholar]
- LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
- Langston J. W., Ballard P., Tetrud J. W., Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science. 1983 Feb 25;219(4587):979–980. doi: 10.1126/science.6823561. [DOI] [PubMed] [Google Scholar]
- Parkes J. D., Marsden C. D., Donaldson I., Galea-Debono A., Walters J., Kennedy G., Asselman P. Bromocriptine treatment in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1976 Feb;39(2):184–193. doi: 10.1136/jnnp.39.2.184. [DOI] [PMC free article] [PubMed] [Google Scholar]